Karen L. Smith Emergent Bio Solutions Inc. (EBS) insider trading activity

EBS Quotes by TradingView

Karen L. Smith is EVP, Chief Medical Officer of Emergent BioSolutions Inc.. Currently has a direct ownership of 11,888 shares of EBS, which is worth approximately $133,740. The most recent transaction as insider was on May 07, 2021, when has been sold 305 shares (Common Stock) at a price of $60.85 per share, resulting in proceeds of $18,559. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.9K
0% 3M change
0% 12M change
Total Value Held $133,740

Karen L. Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 07 2021
SELL
Payment of exercise price or tax liability
$18,559 $60.85 p/Share
305 Reduced 2.5%
11,888 Common Stock
Feb 24 2021
BUY
Grant, award, or other acquisition
-
5,883 Added 32.55%
12,193 Common Stock

Also insider at

XLRN
ACCELERON PHARMA INC Healthcare
Director
SGMO
SANGAMO THERAPEUTICS, INC Healthcare
TALS
Talaris Therapeutics, Inc. Healthcare
Director
CRTX
Cortexyme, Inc. Healthcare
Chief Medical Officer
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
Director
SKYE
Skye Bioscience, Inc. Healthcare
Director
CNTX
Context Therapeutics Inc. Healthcare
Director
KLS

Karen L. Smith

EVP, Chief Medical Officer
Gaithersburg,, MD

Track Institutional and Insider Activities on EBS

Follow Emergent BioSolutions Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EBS shares.

Notify only if

Insider Trading

Get notified when an Emergent Bio Solutions Inc. insider buys or sells EBS shares.

Notify only if

News

Receive news related to Emergent BioSolutions Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EBS